Botanical

White Bryony

Bryonia alba

White bryony (Bryonia alba) is a toxic climbing vine in the cucumber family, once widely used across Scandinavia, Poland, the Baltic states, Ukraine, Romania and the Balkans. Its root was historically used, often as a cheaper stand-in for the more famous mandrake root, to treat fluid swelling (oedema), seizures, intestinal worms, wounds and joint pain, though this use has become obsolete in most of Europe and survives today mainly in isolated Balkan communities. The evidence behind these uses is entirely historical and ethnobotanical rather than clinical, and the plant's berries and fresh root are genuinely toxic.

2

STUDY

11

STUDIED WITH

22

CONDITIONS

6

TRADITIONS

Studies about White Bryony in Akasha →

How it's used

Parts and preparations, and the conditions they're used for.

root · mixed with honey and brandy (oral)Chest Pain · Fever · Arthritis
root · root preparation, current folk use (route varies by indication)Constipation · Edema · Gout · Respiratory Issues · Diarrhea · Epilepsy · Wounds & Skin Ulcers
root · squeezed root, topical applicationArthritis
root (phytochemical assay) · phytochemical extract / pharmacological assayArthritis · Respiratory Issues · Inflammation
root · fresh root juice (root hollowed and left to exude sap)Edema · Intestinal Parasites · Epilepsy · Headaches & Migraines
root · root-based ointment (topical)Pneumonia
root · fresh root slices, topical applicationBruises & Contusions · Wounds & Skin Ulcers
root · grated root plaster/poulticeToothache · Dizziness & Vertigo
fruit (berries) · decoctionSore Throat · Edema
leaf · topical application (direct)Wounds & Skin Ulcers
leaf · compressBruises & Contusions · Bone Fracture
root · mixed with fat (topical salve)Scabies · Wounds & Skin Ulcers

These uses are flagged for review — traditional-use claims kept as reported, never as advice.

What the studies found

Findings backed by a source paper, not traditional use alone.

root · mixed with honey and brandy (oral) — An important Romanian remedy against fever, chest pain and rheumatism, using root mixed with honey and brandy, taken in the morning.

root · root preparation, current folk use (route varies by indication) — Popovic and colleagues recorded current use among Serbs in Deliblato Sands, where the root of 'debelo tikva' retained versatile applications: purgative, diuretic, mucolytic, against dropsy, gout, lung catarrh, diarrhoea, epilepsy, and externally for ulcers and wounds. This is the most recent (contemporary) documented folk use catalogued in the paper.

root · squeezed root, topical application — Current use among ethnic Albanians in Kosovo (local names sterkungulli, kungelli i egre): root squeezed and topically applied to the painful area as an anti-rheumatic agent.

root (phytochemical assay) · phytochemical extract / pharmacological assay — Citing prior separate pharmacological assays, the authors report that B. alba root is rich in cucurbitacins, biologically active compounds known for strong cytotoxic and antitumor action but poisonous in high doses; B. alba roots also have high phenolic and flavonoid content. The recognised pharmacologically documented activities of B. alba are anti-rheumatic, expectorant and anti-inflammatory.

root · fresh root juice (root hollowed and left to exude sap) — 1792 account (Hoffberg) states root juice, collected by hollowing a cut root and leaving it to fill with sap over about a day, 'cured oedema' and was used in the treatment of intestinal worms, convulsions and headaches. Purely descriptive historical testimony; no quantitative outcome data.

root · root-based ointment (topical) — An ointment made from the root was used in cases of pneumonia (Hoffberg, 1792); descriptive historical account only.

root · fresh root slices, topical application — Sweden 1792: slices of the fresh root applied to bruises. Eighteenth-century Swedish physicians separately reported that placing fresh root slices against aches and sores had a curative effect; the root was also deemed effective against parasitic worms and used as a laxative in the same period.

root · grated root plaster/poultice — Central Poland: a plaster made from grated root was used for toothache and described as helpful for dizziness, used as a tonic. An identical remedy was recorded in a Polish herbal from 1693 (Haur), which separately described the root as an excellent remedy against dizziness, as a heart tonic, and as a protector against witchcraft.

fruit (berries) · decoction — Fruits prepared as a decoction were used against sore throat and to reduce oedema in the Lithuanian-Belarus borderland and among Polish-speaking people in present-day Belarus.

leaf · topical application (direct) — Leaves applied to wounds and ulcers in the Lithuanian-Belarus borderland.

leaf · compress — Leaves used externally in compresses to treat contusions, bruises and bone fractures in Lithuania.

root · mixed with fat (topical salve) — In Romania, white bryony was a medicine against wounds, and mixed with fat was used against scabies.

Read the source study →

Studies about White Bryony

2 completed studies · newest first

From medicinal plant to noxious weed: Bryonia alba L. (Cucurbitaceae) in northern and eastern Europe.

Monika Kujawska et al. (2019) · Journal of ethnobiology and ethnomedicine

This historical review examined Bryonia alba (white bryony), a vine in the cucumber family, tracing its use across northern and central-eastern Europe from antiquity through the twentieth century. The authors, an ethnobiologist and an ethnologist, worked from written and oral sources rather than a clinical study, covering Sweden, Denmark, Germany, Poland, Belarus, Ukraine, Romania and the Balkans. White bryony's root closely resembles the root of mandrake (Mandragora officinarum), a plant with an extensive European magical and medicinal reputation; the paper's central finding is that this resemblance let bryony function as mandrake's cheaper stand-in, inheriting much of its folklore in the process. Rather than enrolling participants, the authors searched historical floras, pharmacopoeias, ethnographic monographs, and travel accounts for every mention of the plant, then sorted findings into categories: ritual and folk-belief use, food, folk and historical medicine, ethnoveterinary practice, and ornamental planting. They cross-checked, where sources allowed, whether a given account referred to B. alba or its close relative B. dioica, and separated practices documented only in printed herbals ("booklore") from those recorded as living oral tradition passed between households. Across independent sources, root preparations were repeatedly recorded for oedema (fluid swelling, called dropsy at the time), convulsions and epilepsy, intestinal worms, wounds, and rheumatic pain — a 1792 Swedish account describes juice collected from a hollowed-out root curing oedema and treating worms, convulsions and headache, while twentieth- and twenty-first-century accounts from Serbia and Kosovo describe the same root used as a purgative, diuretic and topical anti-rheumatic agent. The authors cite phytochemical literature attributing these effects to cucurbitacins (bitter plant compounds), also linked elsewhere to antitumor activity, while stating plainly that historical claims for epilepsy specifically lack sufficient supporting study. Toxicity is dose- and season-dependent: freshly harvested summer root contains the more toxic cucurbitacin I, and the berries carry a cited lethal dose of roughly 15 for a child and 40 for an adult. The authors report that medicinal use had become obsolete across Scandinavia, Germany and western Slavic regions by the twentieth century, surviving only in isolated Balkan communities in Serbia and Kosovo. The authors present this decline as an unusual case: a plant of substantial historical medicinal and magical importance that today survives mainly as an ornamental garden relic or, in North America, as an unrelated invasive weed. Because the review synthesizes historical and ethnographic records rather than testing the plant directly, it offers no controlled data on safety or effectiveness, and the authors themselves flag some recorded folklore as possibly the invention of root sellers rather than genuine tradition. Future work, the authors suggest, could extend this same source-based method to B. dioica across German-, Latin- and Celtic-speaking Europe.

Read summary →Full text available

Homeopathy for COVID-19 in primary care: A randomized, double-blind, placebo-controlled trial (COVID-Simile study).

Ubiratan Cardinalli Adler et al. (2022) · Journal of integrative medicine

This randomized, double-blind, placebo-controlled trial with 86 analyzed participants explored whether a homeopathic remedy could help people recover faster from mild COVID-19 while isolating at home in Brazil. Homeopathy is a medical system built on the "principle of similars" - the idea that a highly diluted substance capable of causing symptoms in a healthy person can treat similar symptoms in someone who is sick. The remedy tested, Natrum muriaticum (a homeopathic preparation of sodium chloride, common salt), was prepared using Samuel Hahnemann's fifty-millesimal (LM) method: repeated 1:50,000 dilutions with vigorous shaking (succussion) between steps, governing how homeopaths believe a remedy's potency rises as its material dose falls. Adults with a positive PCR test for SARS-CoV-2 and flu-like symptoms were randomly assigned to take drops of Natrum muriaticum LM2 or an identical-looking placebo every six hours (more often if symptoms were severe) during home isolation. Researchers tracked recovery by phone and WhatsApp, asking participants to rate 15 to 17 symptoms - including cough, fatigue, and loss of smell or taste - on a 0-to-3 severity scale, then combined these into a daily symptom score analyzed with Kaplan-Meier survival curves, the statistical method used to track time-to-event outcomes like recovery. The main result was a null one: time to full symptom recovery did not differ significantly between the homeopathy and placebo groups (P = 0.56 overall, P = 0.06 among the most symptomatic participants) - homeopathy showed a numerically shorter median recovery time (3 days versus 6 days) in the sicker subgroup, but the gap was not statistically reliable. A secondary analysis told a more encouraging, though still tentative, story: among participants who started with a high symptom burden, those taking homeopathy reached a 50% reduction in symptoms significantly faster than those on placebo (P = 0.04), improving roughly 0.9 days sooner over the first five days (P = 0.022) - though this edge disappeared by day 7 and day 10, suggesting it may reflect the natural course of a self-limiting illness rather than a true treatment effect. Hospitalization was numerically lower with homeopathy (2.4% versus 6.8%) but not statistically significant, and side effects were mild and similar between groups. For patients and clinicians, this trial does not provide evidence to recommend homeopathic Natrum muriaticum LM2 as a COVID-19 treatment - the confidence intervals around the promising secondary findings were too wide to draw firm conclusions, and the study fell short of its planned 90-participant sample after dropouts left 86. Baseline differences between groups, including more respiratory disease in the homeopathy arm, add further uncertainty. The authors frame this as a pioneering but inconclusive first step, calling for larger, more targeted trials - particularly in patients with more severe symptoms at enrollment - before homeopathy's role in COVID-19 care can be assessed.

Read summary →Full text available